Acquisition - Summary of Preliminary Allocation of Total Purchase Price (Detail) - USD ($) |
Nov. 30, 2019 |
Nov. 30, 2018 |
Jun. 11, 2018 |
|---|---|---|---|
| Business Acquisition [Line Items] | |||
| Goodwill | $ 1,941,411 | $ 1,941,411 | |
| Blood Bank Inc and Tianhe Stem Cell Biotechnologies Inc [Member] | |||
| Business Acquisition [Line Items] | |||
| Accounts receivable | $ 188,019 | ||
| Inventory | 16,037,957 | ||
| Prepaid expenses | 68,867 | ||
| Property and equipment | 568,407 | ||
| Other asset - Tianhe capital stock | 308,000 | ||
| Total identifiable net assets acquired | 18,162,250 | ||
| Less: Deferred revenue | (1,405,406) | ||
| Goodwill | 1,941,411 | ||
| Total | 18,698,255 | ||
| Blood Bank Inc and Tianhe Stem Cell Biotechnologies Inc [Member] | Brand [Member] | |||
| Business Acquisition [Line Items] | |||
| Intangible assets | 31,000 | ||
| Blood Bank Inc and Tianhe Stem Cell Biotechnologies Inc [Member] | Customer Relationships [Member] | |||
| Business Acquisition [Line Items] | |||
| Intangible assets | $ 960,000 |
| X | ||||||||||
- Definition Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current And Noncurrent Liabilities Deferred Revenue No definition available.
|
| X | ||||||||||
- Definition Business combination, recognized identifiable assets acquired and liabilities assumed, current assets, prepaid expenses. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of assets acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of inventory recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|